AFC-HD AMS Life Science Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	n/a
Permanencia media de la dirección	21.7yrs
Promedio de permanencia en la Junta Directiva	3.5yrs

Actualizaciones recientes de la dirección

Recent updates

AFC-HD AMS Life Science (TSE:2927) Is Due To Pay A Dividend Of ¥15.00

Apr 17

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Might Deserve Your Attention Today

Apr 29

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Safely

Apr 14

AFC-HD AMS Life Science Co., Ltd.'s (TYO:2927) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 09

Is It Smart To Buy AFC-HD AMS Life Science Co., Ltd. (TYO:2927) Before It Goes Ex-Dividend?

Feb 20

The Trends At AFC-HD AMS Life Science (TYO:2927) That You Should Know About

Feb 04

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Is An Interesting Stock

Jan 17

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Reasonably Well

Dec 29

AFC-HD AMS Life Science Co., Ltd. (TYO:2927) On An Uptrend: Could Fundamentals Be Driving The Stock?

Dec 02

CEO

AFC-HD AMS Life Science no tiene CEO, o no tenemos datos al respecto.

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Nobue Hamabe	Accounting Manager & Director	21.7yrs	sin datos	0.17% ¥ 20.5m
Naoya Unno	GM of Technical Development Division & Director	21.7yrs	sin datos	0.24% ¥ 28.5m
Shigenori Fukuchi	Senior MD	18.5yrs	sin datos	0.29% ¥ 35.4m

21.7yrs

Permanencia media

54yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 2927 es experimentado (21.6 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Nobue Hamabe	Accounting Manager & Director	1.5yrs	sin datos	0.17% ¥ 20.5m
Naoya Unno	GM of Technical Development Division & Director	20.7yrs	sin datos	0.24% ¥ 28.5m
Shigenori Fukuchi	Senior MD	20.7yrs	sin datos	0.29% ¥ 35.4m
Takehiko Asayama	Chairman	22.8yrs	JP¥234.60m	8.46% ¥ 1.0b
Hiroshi Unno	Independent Outside Director	3.5yrs	sin datos	0.022% ¥ 2.7m
Shigeo Minakata	Director	2.5yrs	sin datos	0.041% ¥ 4.9m
Shunji Sasahara	Director	3.5yrs	sin datos	0.036% ¥ 4.3m

3.5yrs

Permanencia media

54yo

Promedio de edad

Junta con experiencia: La junta directiva de 2927 se considera experimentada (3.4 años de antigüedad promedio).

AFC-HD AMS Life Science Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 28, 2023

No independent directors

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 29, 2022

No independent directors

Recent updates

AFC-HD AMS Life Science (TSE:2927) Is Due To Pay A Dividend Of ¥15.00

First half dividend of JP¥15.00 announced

Second quarter 2024 earnings released: EPS: JP¥22.99 (vs JP¥18.05 in 2Q 2023)

AFC-HD AMS Life Science Co., Ltd. to Report Q2, 2024 Results on Apr 15, 2024

Upcoming dividend of JP¥15.00 per share

First quarter 2024 earnings released: EPS: JP¥22.76 (vs JP¥11.40 in 1Q 2023)

AFC-HD AMS Life Science Co., Ltd. to Report Q1, 2024 Results on Jan 12, 2024

Full year 2023 earnings released: EPS: JP¥77.12 (vs JP¥52.31 in FY 2022)

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 28, 2023

Upcoming dividend of JP¥15.00 per share at 3.0% yield

AFC-HD AMS Life Science Co., Ltd. to Report Fiscal Year 2023 Results on Oct 13, 2023

Third quarter 2023 earnings released: EPS: JP¥19.05 (vs JP¥16.25 in 3Q 2022)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023

AFC-HD AMS Life Science Co., Ltd. (TSE:2927) announces an Equity Buyback for 100,000 shares, representing 0.71% for ¥100 million.

AFC-HD AMS Life Science Co., Ltd. to Report Q3, 2023 Results on Jul 14, 2023

Second quarter 2023 earnings released: EPS: JP¥18.05 (vs JP¥10.79 in 2Q 2022)

Upcoming dividend of JP¥12.50 per share at 3.1% yield

AFC-HD AMS Life Science Co., Ltd. to Report Q2, 2023 Results on Apr 14, 2023

Investor sentiment improves as stock rises 16%

First quarter 2023 earnings released: EPS: JP¥11.40 (vs JP¥11.03 in 1Q 2022)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023

AFC-HD AMS Life Science Co., Ltd. (TSE:2927) agreed to acquire a 51% stake in 5SPRO Joint Stock Company.

Full year 2022 earnings released: EPS: JP¥52.31 (vs JP¥107 in FY 2021)

AFC-HD AMS Life Science Co., Ltd. to Report Q1, 2023 Results on Jan 13, 2023

No independent directors

Full year 2022 earnings released: EPS: JP¥52.31 (vs JP¥107 in FY 2021)

AFC-HD AMS Life Science Co., Ltd., Annual General Meeting, Nov 29, 2022

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending February 2023 and August 2023

AFC-HD AMS Life Science Co., Ltd. to Report Fiscal Year 2022 Results on Oct 14, 2022

Upcoming dividend of JP¥15.00 per share

Third quarter 2022 earnings released: EPS: JP¥16.25 (vs JP¥45.13 in 3Q 2021)

AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Period Ending August 2022

AFC-HD AMS Life Science Co., Ltd. to Report Q3, 2022 Results on Jul 15, 2022

No independent directors

AFC-HD AMS Life Science Co., Ltd. Announces Dividend for the Second Quarter of 2022, Payable on May 16, 2022

Second quarter 2022 earnings released: EPS: JP¥10.79 (vs JP¥25.92 in 2Q 2021)

AFC-HD AMS Life Science Co., Ltd. to Report Q2, 2022 Results on Apr 14, 2022

Upcoming dividend of JP¥15.00 per share

Investor sentiment deteriorated over the past week

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: EPS JP¥107 (vs JP¥48.07 in FY 2020)

Upcoming dividend of JP¥15.00 per share

Third quarter 2021 earnings released: EPS JP¥45.13 (vs JP¥6.33 in 3Q 2020)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 2021

Investor sentiment improved over the past week

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Might Deserve Your Attention Today

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Safely

Second quarter 2021 earnings released: EPS JP¥25.92 (vs JP¥13.58 in 2Q 2020)

AFC-HD AMS Life Science Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending August 2021

AFC-HD AMS Life Science Co., Ltd.'s (TYO:2927) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Is It Smart To Buy AFC-HD AMS Life Science Co., Ltd. (TYO:2927) Before It Goes Ex-Dividend?

New 90-day high: JP¥1,115

The Trends At AFC-HD AMS Life Science (TYO:2927) That You Should Know About

New 90-day high: JP¥1,088

Here's Why I Think AFC-HD AMS Life Science (TYO:2927) Is An Interesting Stock

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JP¥26.88

New 90-day high: JP¥798

These 4 Measures Indicate That AFC-HD AMS Life Science (TYO:2927) Is Using Debt Reasonably Well

AFC-HD AMS Life Science Co., Ltd. (TYO:2927) On An Uptrend: Could Fundamentals Be Driving The Stock?

AFC-HD AMS Life Science Co., Ltd. Announces Year End Dividend for the Fiscal Year Ended August 31, 2020, Payable on November 26, 2020

Full year earnings released - EPS JP¥48.07

New 90-day low - JP¥674

Upcoming Dividend of JP¥10.00 Per Share

AFC-HD AMS Life Science Co., Ltd. to Report Fiscal Year 2020 Results on Oct 09, 2020

New 90-day high - JP¥705

New 90-day high - JP¥692

CEO

Equipo directivo

Permanencia media

Promedio de edad